The progression of severe aplastic anemia to hypoplastic leukemia in a long-term observation after the administration of pegylated rHuMGDF.

Ishikawa, Maho; Matsuda, Akira; Okamura, Daisuke; Maeda, Tomoya; Kawai, Nobutaka; Asou, Norio; Bessho, Masami.

Ishikawa M; Department of Hemato-Oncology, Saitama Medical University International Medical Center, Hidaka, Saitama, Japan.
Matsuda A; Department of Hemato-Oncology, Saitama Medical University International Medical Center, Hidaka, Saitama, Japan.
Okamura D; Department of Hemato-Oncology, Saitama Medical University International Medical Center, Hidaka, Saitama, Japan.
Maeda T; Department of Hemato-Oncology, Saitama Medical University International Medical Center, Hidaka, Saitama, Japan.
Kawai N; Department of Hemato-Oncology, Saitama Medical University International Medical Center, Hidaka, Saitama, Japan.
Asou N; Department of Hemato-Oncology, Saitama Medical University International Medical Center, Hidaka, Saitama, Japan.
Bessho M; Department of Hemato-Oncology, Saitama Medical University International Medical Center, Hidaka, Saitama, Japan.

Hematol Rep ; 10(3): 7679, 2018 Sep 05.

Article en En | MEDLINE | ID: mdl-30283622